TY - JOUR
T1 - Dietary fat, fat subtypes and hepatocellular carcinoma in a large European cohort
AU - Duarte-Salles, Talita
AU - Fedirko, Veronika
AU - Stepien, Magdalena
AU - Aleksandrova, Krasimira
AU - Bamia, Christina
AU - Lagiou, Pagona
AU - Laursen, Anne Sofie Dam
AU - Hansen, Louise
AU - Overvad, Kim
AU - Tjønneland, Anne
AU - Boutron-Ruault, Marie Christine
AU - Fagherazzi, Guy
AU - His, Mathilde
AU - Boeing, Heiner
AU - Katzke, Verena
AU - Kühn, Tilman
AU - Trichopoulou, Antonia
AU - Valanou, Elissavet
AU - Kritikou, Maria
AU - Masala, Giovanna
AU - Panico, Salvatore
AU - Sieri, Sabina
AU - Ricceri, Fulvio
AU - Tumino, Rosario
AU - Bueno-De-Mesquita, H. B.
AU - Peeters, Petra H.
AU - Skeie, Guri
AU - Weiderpass, Elisabete
AU - Ardanaz, Eva
AU - Bonet, Catalina
AU - Chirlaque, Maria Dolores
AU - Dorronsoro, Miren
AU - Quirõs, J. Ramõn
AU - Johansson, Ingegerd
AU - Ohlsson, Bodil
AU - Sjöberg, Klas
AU - Wennberg, Maria
AU - Khaw, Kay Tee
AU - Travis, Ruth C.
AU - Wareham, Nick
AU - Ferrari, Pietro
AU - Freisling, Heinz
AU - Romieu, Isabelle
AU - Cross, Amanda J.
AU - Gunter, Marc
AU - Lu, Yunxia
AU - Jenab, Mazda
N1 - Publisher Copyright:
© 2015 UICC.
PY - 2015/12/1
Y1 - 2015/12/1
N2 - The role of amount and type of dietary fat consumption in the etiology of hepatocellular carcinoma (HCC) is poorly understood, despite suggestive biological plausibility. The associations of total fat, fat subtypes and fat sources with HCC incidence were investigated in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort, which includes 191 incident HCC cases diagnosed between 1992 and 2010. Diet was assessed by country-specific, validated dietary questionnaires. A single 24-hr diet recall from a cohort subsample was used for measurement error calibration. Hazard ratios (HR) and 95% confidence intervals (95% CI) were estimated from Cox proportional hazard models. Hepatitis B and C viruses (HBV/HCV) status and biomarkers of liver function were assessed separately in a nested case-control subset with available blood samples (HCC = 122). In multivariable calibrated models, there was a statistically significant inverse association between total fat intake and risk of HCC (per 10 g/day, HR = 0.80, 95% CI: 0.65-0.99), which was mainly driven by monounsaturated fats (per 5 g/day, HR = 0.71, 95% CI: 0.55-0.92) rather than polyunsaturated fats (per 5 g/day, HR = 0.92, 95% CI: 0.68-1.25). There was no association between saturated fats (HR = 1.08, 95% CI: 0.88-1.34) and HCC risk. The ratio of polyunsaturated/monounsaturated fats to saturated fats was not significantly associated with HCC risk (per 0.2 point, HR = 0.86, 95% CI: 0.73-1.01). Restriction of analyses to HBV/HCV free participants or adjustment for liver function did not substantially alter the findings. In this large prospective European cohort, higher consumption of monounsaturated fats is associated with lower HCC risk. What's new? The rise of hepatocellular carcinoma (HCC) incidence in high- and middle-income countries, where relatively high-fat diets are common, suggests a possible etiological role for dietary fat. In the present study, potential associations between HCC and total fat intake, intake of fat subtypes and intake of fat from different sources were explored with data from the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Total fat intake, where monounsaturated fats predominated, was inversely associated with HCC risk. By contrast, no risk associations were detected for polyunsaturated or saturated fat intake or fat source.
AB - The role of amount and type of dietary fat consumption in the etiology of hepatocellular carcinoma (HCC) is poorly understood, despite suggestive biological plausibility. The associations of total fat, fat subtypes and fat sources with HCC incidence were investigated in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort, which includes 191 incident HCC cases diagnosed between 1992 and 2010. Diet was assessed by country-specific, validated dietary questionnaires. A single 24-hr diet recall from a cohort subsample was used for measurement error calibration. Hazard ratios (HR) and 95% confidence intervals (95% CI) were estimated from Cox proportional hazard models. Hepatitis B and C viruses (HBV/HCV) status and biomarkers of liver function were assessed separately in a nested case-control subset with available blood samples (HCC = 122). In multivariable calibrated models, there was a statistically significant inverse association between total fat intake and risk of HCC (per 10 g/day, HR = 0.80, 95% CI: 0.65-0.99), which was mainly driven by monounsaturated fats (per 5 g/day, HR = 0.71, 95% CI: 0.55-0.92) rather than polyunsaturated fats (per 5 g/day, HR = 0.92, 95% CI: 0.68-1.25). There was no association between saturated fats (HR = 1.08, 95% CI: 0.88-1.34) and HCC risk. The ratio of polyunsaturated/monounsaturated fats to saturated fats was not significantly associated with HCC risk (per 0.2 point, HR = 0.86, 95% CI: 0.73-1.01). Restriction of analyses to HBV/HCV free participants or adjustment for liver function did not substantially alter the findings. In this large prospective European cohort, higher consumption of monounsaturated fats is associated with lower HCC risk. What's new? The rise of hepatocellular carcinoma (HCC) incidence in high- and middle-income countries, where relatively high-fat diets are common, suggests a possible etiological role for dietary fat. In the present study, potential associations between HCC and total fat intake, intake of fat subtypes and intake of fat from different sources were explored with data from the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Total fat intake, where monounsaturated fats predominated, was inversely associated with HCC risk. By contrast, no risk associations were detected for polyunsaturated or saturated fat intake or fat source.
KW - European populations
KW - cohort study
KW - dietary fats
KW - hepatocellular carcinoma
UR - http://www.scopus.com/inward/record.url?scp=84941746153&partnerID=8YFLogxK
U2 - 10.1002/ijc.29643
DO - 10.1002/ijc.29643
M3 - Article
C2 - 26081477
AN - SCOPUS:84941746153
SN - 0020-7136
VL - 137
SP - 2715
EP - 2728
JO - International Journal of Cancer
JF - International Journal of Cancer
IS - 11
ER -